1
项与 Humanized CD25 Monoclonal Antibody(Institute of Hematology & Blood Diseases Hospital) 相关的临床试验An Exploratory Clinical Study on the Efficacy and Safety of Humanized CD25 Monoclonal Antibody Combined With Glucocorticoid in the First-line Treatment of Acute Graft-versus-host Disease (aGVHD) After Allo-HSCT
The first-line treatment of acute graft-versus-host disease with humanized CD25 monoclonal antibody combined with glucocorticoid was used to study the remission rate of acute graft-versus-host disease, the cumulative incidence and remission rate of severe acute graft-versus-host disease, GVHD-free survival rate, all-cause mortality and quality of life evaluation, and safety evaluation for prevention programs.
100 项与 Humanized CD25 Monoclonal Antibody(Institute of Hematology & Blood Diseases Hospital) 相关的临床结果
100 项与 Humanized CD25 Monoclonal Antibody(Institute of Hematology & Blood Diseases Hospital) 相关的转化医学
100 项与 Humanized CD25 Monoclonal Antibody(Institute of Hematology & Blood Diseases Hospital) 相关的专利(医药)
100 项与 Humanized CD25 Monoclonal Antibody(Institute of Hematology & Blood Diseases Hospital) 相关的药物交易